Skip to Content

Join the 'Premarin' group to help and get support from people like you.

Premarin News

Could Hormone Supplements for Menopause Make a Comeback?

Posted 12 Sep 2017 by Drugs.com

TUESDAY, Sept. 12, 2017 – The door may be opening again for menopausal women suffering from hot flashes and night sweats to receive some relief from a source once thought too dangerous to consider, researchers say. Hormone replacement therapy to treat symptoms of menopause does not increase a woman's risk of early death – either overall or specifically from cancer or heart disease, according to...

Hormone Replacement Therapy Tied to Hearing Loss

Posted 12 May 2017 by Drugs.com

FRIDAY, May 12, 2017 – Hearing loss has been linked to several factors associated with menopause, a new study says. One factor is your age at menopause. An older age is tied to a higher risk of hearing troubles. And, a second factor is the use of oral hormone therapy to ease some of the symptoms of menopause. The researchers also found that the longer a woman used hormone therapy, the greater...

HRT Won't Lower Women's Alzheimer's Risk, Study Finds

Posted 16 Feb 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – Women who use hormone therapy after menopause may not have a lower risk of developing Alzheimer's, a new study suggests. However, there was some evidence that long-term use – over a decade – might be tied to a lower risk of the memory-robbing brain disease. But the results were far from definitive, the researchers added. The study is the latest to delve into the...

Fat Near the Heart a Hazard for Postmenopausal Women

Posted 31 Jan 2017 by Drugs.com

TUESDAY, Jan. 31, 2017 – When a certain type of fat collects around the heart, it may be a sign of developing heart disease in postmenopausal women, a new study suggests. As estrogen levels fall during menopause, deposits of "paracardial" fat increase, the researchers found. This may cause more calcium build-up in the heart's arteries, an early sign of heart disease. Paracardial fat sits in...

New Drug Combo Shows Promise Curbing Tough-to-Treat Breast Cancer

Posted 8 Dec 2016 by Drugs.com

THURSDAY, Dec. 8, 2016 – In women with a certain form of tough-to-treat breast cancer, treatment with a combination of two drugs appeared to keep the cancer at bay longer – from about five months to 10, a new study says. The cancer is known as "advanced hormone receptor positive, HER 2 negative" breast cancer. Women with these tumors are often given drugs called aromatase inhibitors, which work...

Breast Cancer Cells May Change When They Spread to Brain: Study

Posted 7 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 7, 2016 – When breast cancer spreads to the brain, important molecular changes may occur in the cancer, a small study found. The discovery of these changes could lead to improved diagnosis and treatment, the researchers said. About 20 percent of breast cancers are a type known as HER2-positive, which typically respond to targeted therapies. However, HER2-negative breast cancer...

Hormone Therapy Won't Help Memory After Menopause

Posted 19 Jul 2016 by Drugs.com

TUESDAY, July 19, 2016 – Women who take estrogen after menopause may believe it helps them maintain their memory and thinking skills, but a new study suggests they are mistaken. Researchers found no change in mental ability associated with estrogen therapy among women who used it after menopause, no matter when they started taking it. "There is no important benefit, there is no important risk...

Exploring the Link Between Estrogen and Migraines

Posted 1 Jun 2016 by Drugs.com

WEDNESDAY, June 1, 2016 – Researchers are getting a better understanding of the link between estrogen levels and migraine headaches in women. A new study finds that for women who get these intense headaches, levels of the hormone estrogen drop more rapidly in the days before menstruation than in women without the headaches. "These results suggest that a 'two-hit' process may link estrogen...

FDA Medwatch Alert: Premarin (conjugated estrogens)

Posted 26 Sep 2002 by Drugs.com

FDA and Wyeth notified healthcare professionals about safety related labeling changes to the INDICATIONS and USAGE, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and DOSAGE and ADMINISTRATION sections of the labels. The new safety information reflects new data, primarily from the Women's Health Initiative (WHI).[August 28, 2002 Letter - Wyeth][August 13, 2002 FDA Statement on the Results of the...

Ask a Question

Further Information

Related Condition Support Groups

Atrophic Vaginitis, Postmenopausal Symptoms, Abnormal Uterine Bleeding, Osteoporosis, Prostate Cancer

Premarin Patient Information at Drugs.com